Back to Journals » Infection and Drug Resistance » Integrating One Health in Infectious Disease Prevention and Control
Infection and Drug Resistance
- View all (4828)
- Volume 19, 2026 (270)
- Volume 18, 2025 (601)
- Volume 17, 2024 (563)
- Volume 16, 2023 (705)
- Volume 15, 2022 (735)
- Volume 14, 2021 (553)
- Volume 13, 2020 (470)
- Volume 12, 2019 (399)
- Volume 11, 2018 (262)
- Volume 10, 2017 (60)
- Volume 9, 2016 (34)
- Volume 8, 2015 (39)
- Volume 7, 2014 (38)
- Volume 6, 2013 (25)
- Volume 5, 2012 (20)
- Volume 4, 2011 (23)
- Volume 3, 2010 (16)
- Volume 2, 2009 (5)
- Volume 1, 2008 (10)
Journal Articles:
- Unlocking Drug Resistance Prediction with AI (3)
- Emerging Trends in Multidrug-Resistant Infections (5)
- Personalized Antimicrobial Strategies: A Path to Precision Therapy (2)
- Antimicrobial Stewardship and Infection Control: A Global Perspective (4)
- Advances in Prosthetic Joint Infections: Current Challenges and Future Solutions (2)
- Current aspects of fungal infections (1)
- Advances in Osteomyelitis: Pathogenesis, Diagnosis, and Treatment (1)
- Respiratory Syncytial Virus (RSV): progress, challenges and outcomes (6)
Integrating One Health in Infectious Disease Prevention and Control
It is increasingly recognized that the management of infectious diseases can be improved through intersectoral or interdisciplinary collaborations. One of the most prominent examples is the development of the rabies vaccine, which first demonstrated efficacy in dogs and was later adapted as post-exposure prophylaxis in humans. In 1964, Calvin Schwabe, a distinguished veterinarian and epidemiologist, coined the term “One Medicine” in response to the separation of human and veterinary medicine. This concept was later reintroduced in the 21st century and evolved into “One Health.” Following its adoption and advocacy by public health agencies, One Health is now defined as “an integrated, unifying approach that aims to sustainably balance and optimize the health of humans, animals, plants, and ecosystems.
